Financial Counselors Inc’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-243,291
| Closed | -$6.16M | – | 395 |
|
|
2025
Q1 | $6.16M | Sell |
243,291
-8,439
| -3% | -$221K | 0.09% | 176 |
|
|
2024
Q4 | $6.68M | Sell |
251,730
-8,352
| -3% | -$227K | 0.1% | 171 |
|
|
2024
Q3 | $7.53M | Sell |
260,082
-18,400
| -7% | -$537K | 0.11% | 160 |
|
|
2024
Q2 | $7.79M | Sell |
278,482
-24,262
| -8% | -$668K | 0.13% | 153 |
|
|
2024
Q1 | $8.4M | Sell |
302,744
-217,515
| -42% | -$6.04M | 0.14% | 147 |
|
|
2023
Q4 | $15M | Sell |
520,259
-42,890
| -8% | -$1.3M | 0.27% | 101 |
|
|
2023
Q3 | $18.7M | Sell |
563,149
-5,324
| -0.9% | -$188K | 0.37% | 74 |
|
|
2023
Q2 | $20.9M | Sell |
568,473
-1,058
| -0.2% | -$41.2K | 0.42% | 65 |
|
|
2023
Q1 | $23.2M | Sell |
569,531
-6,540
| -1% | -$282K | 0.5% | 57 |
|
|
2022
Q4 | $29.5M | Buy |
576,071
+4,938
| +0.9% | +$237K | 0.66% | 44 |
|
|
2022
Q3 | $25M | Buy |
571,133
+4,097
| +0.7% | +$199K | 0.62% | 49 |
|
|
2022
Q2 | $29.7M | Buy |
567,036
+19,794
| +4% | +$1.01M | 0.7% | 39 |
|
|
2022
Q1 | $28.3M | Buy |
547,242
+5,734
| +1% | +$298K | 0.59% | 51 |
|
|
2021
Q4 | $32M | Sell |
541,508
-42,384
| -7% | -$2.1M | 0.66% | 45 |
|
|
2021
Q3 | $25.1M | Sell |
583,892
-11,976
| -2% | -$531K | 0.54% | 56 |
|
|
2021
Q2 | $23.3M | Sell |
595,868
-5,049
| -0.8% | -$196K | 0.51% | 60 |
|
|
2021
Q1 | $21.8M | Sell |
600,917
-7,049
| -1% | -$250K | 0.51% | 60 |
|
|
2020
Q4 | $22.4M | Sell |
607,966
-81,335
| -12% | -$2.98M | 0.56% | 53 |
|
|
2020
Q3 | $24M | Sell |
689,301
-47,872
| -6% | -$1.68M | 0.7% | 41 |
|
|
2020
Q2 | $22.9M | Buy |
737,173
+135,569
| +23% | +$4.61M | 0.73% | 36 |
|
|
2020
Q1 | $18.6M | Sell |
601,604
-32,918
| -5% | -$1.12M | 0.83% | 32 |
|
|
2019
Q4 | $23.6M | Sell |
634,522
-1,112
| -0.2% | -$39.6K | 0.84% | 28 |
|
|
2019
Q3 | $21.7M | Buy |
635,634
+27,664
| +5% | +$1.01M | 0.85% | 26 |
|
|
2019
Q2 | $25M | Sell |
607,970
-14,024
| -2% | -$557K | 1.02% | 17 |
|
|
2019
Q1 | $25.1M | Buy |
621,994
+10,501
| +2% | +$421K | 1.06% | 15 |
|
|
2018
Q4 | $25.3M | Sell |
611,493
-4,975
| -0.8% | -$207K | 1.25% | 11 |
|
|
2018
Q3 | $25.8M | Sell |
616,468
-45,155
| -7% | -$1.74M | 1.13% | 13 |
|
|
2018
Q2 | $22.8M | Sell |
661,623
-817
| -0.1% | -$27.9K | 1.05% | 17 |
|
|
2018
Q1 | $22.3M | Buy |
662,440
+6,587
| +1% | +$226K | 1.06% | 15 |
|
|
2017
Q4 | $22.5M | Buy |
655,853
+4,161
| +0.6% | +$142K | 1.03% | 17 |
|
|
2017
Q3 | $22.1M | Sell |
651,692
-316
| -0% | -$10.2K | 1.08% | 13 |
|
|
2017
Q2 | $20.8M | Buy |
652,008
+2,726
| +0.4% | +$86K | 1.03% | 14 |
|
|
2017
Q1 | $21.1M | Buy |
649,282
+16,386
| +3% | +$517K | 1.08% | 13 |
|
|
2016
Q4 | $19.5M | Buy |
+632,896
| New | +$19.3M | 1.04% | 15 |
|
|
2016
Q2 | $17.9M | Buy |
535,900
+9,081
| +2% | +$290K | 1.07% | 15 |
|
|
2016
Q1 | $14.8M | Sell |
526,819
-1,006
| -0.2% | -$28.7K | 0.92% | 18 |
|
|
2015
Q4 | $16.2M | Buy |
527,825
+48,290
| +10% | +$1.52M | 1.04% | 14 |
|
|
2015
Q3 | $14.3M | Sell |
479,535
-30
| -0% | -$962 | 0.98% | 17 |
|
|
2015
Q2 | $15.3M | Sell |
479,565
-14,069
| -3% | -$459K | 0.97% | 20 |
|
|
2015
Q1 | $16.3M | Sell |
493,634
-11,881
| -2% | -$378K | 1.01% | 15 |
|
|
2014
Q4 | $14.9M | Sell |
505,515
-68,493
| -12% | -$1.96M | 0.95% | 20 |
|
|
2014
Q3 | $16.1M | Buy |
574,008
+25,595
| +5% | +$718K | 1.13% | 14 |
|
|
2014
Q2 | $15.4M | Buy |
548,413
+79,665
| +17% | +$2.27M | 1.08% | 14 |
|
|
2014
Q1 | $14.3M | Sell |
468,748
-1,702
| -0.4% | -$50.7K | 1.03% | 19 |
|
|
2013
Q4 | $13.7M | Buy |
470,450
+32,238
| +7% | +$938K | 1.02% | 19 |
|
|
2013
Q3 | $11.9M | Buy |
438,212
+8,844
| +2% | +$241K | 0.99% | 18 |
|
|
2013
Q2 | $11.4M | Buy |
+429,368
| New | +$11.9M | 0.95% | 24 |
|
Other funds holding PFE
Financial Counselors Inc's PFE Position: Q2 2025 in Review
Financial Counselors Inc sold out of Pfizer (PFE) in Q2 2025, closing a stake of 243,291 shares — an estimated $6.16M sold.
Financial Counselors Inc first reported a position in PFE in Q2 2013 and held it in 47 quarters. The position peaked at $32M in Q4 2021. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Financial Counselors Inc reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Financial Counselors Inc sold 243,291 Pfizer shares in Q2 2025, an estimated $6.16M.
- Financial Counselors Inc first reported a position in Pfizer in Q2 2013 and held it in 47 quarters.
- Financial Counselors Inc's Pfizer position peaked at $32M in Q4 2021.
- 2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Financial Counselors Inc's 13F filing for Q2 2025, filed 1 Aug 2025.